[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"gynecologic-surgical-procedures\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:gynecologic-surgical-procedures":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,51,83,113],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":33,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100372519","phase-4-intraperitoneal-infusion-of-analgesic-for-postoperative-pain-management-100372519",false,"NCT04130464","Intraperitoneal Infusion of Analgesic for Postoperative Pain Management","The Impact of the Continuous Infusion of Intraperitoneal Analgesics on Postoperative Pain After Minimally Invasive Hysterectomy: a Randomized Controlled Trial","ON-Q","Inclusion Criteria:\n\n* Hysterectomy planned for a benign gynecologic reason (no evidence of, or concern for, malignancy in the cervix, uterus, tubes or ovaries. Benign gynecologic reasons to have a hysterectomy include fibroids, abnormal uterine bleeding, endometriosis, and pelvic pain.)\n* Patient is scheduled to have surgery with a fellowship trained minimally invasive gynecologic surgeons at one of the study sites.\n* Patient is planned for a robotic assisted total laparoscopic hysterectomy (RA-TLH) or a total laparoscopic hysterectomy (TLH).\n* Patient is capable of informed consent.\n* Patient is capable of completing the questionnaires.\n\nExclusion Criteria:\n\n* Concern for malignancy\n* The procedure is scheduled outside MIGS department.\n* Allergy to any study related medication (i.e. Ketorolac and Ropivacaine)\n* Patient is enrolled in another pain management study.",true,"FEMALE","18 Years","65 Years",{"count":22,"type":23},120,"ESTIMATED","INTERVENTIONAL",[26],"PHASE4","The study is a prospective, double-blinded, placebo-controlled multi-center trial to measure if postoperative pain and the amount of narcotics used are reduced by a clinically significant amount in women undergoing minimally invasive hysterectomy receiving a continuous infusion of intraperitoneal (IP) local anesthetic (LA) or a continuous infusion of LA combined with an NSAID compared with a control group who receives only 0.9% normal saline.",[29,30,31,32],"Hysterectomy","Gynecologic Surgical Procedures","Narcotic Use","Pain, Postoperative",[34,35,36,37],"Intraperitoneal","Pain Pump","Ropivacaine","Ketorolac Tromethamine","RECRUITING","2026-04-03",{"date":41,"type":42},"2026-04-09","ACTUAL",{"date":44,"type":42},"2019-09-30",{"date":46,"type":23},"2026-12",{"name":48,"class":49},"Ying Liu","OTHER",2,{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":59,"targetDuration":4,"studyType":24,"phases":61,"briefSummary":63,"conditions":64,"keywords":65,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":50},"100374378","optical-biopsy-in-gynecological-surgery-100374378","NCT04154683","Optical Biopsy in Gynecological Surgery","Diagnostic Performance of Optical Biopsy by Cellvizio® in Gynecological Surgery","GYNECOPTIC","Inclusion Criteria:\n\n* Women aged 18 years or more\n* Informed and signed consent\n* Planned surgery under laparoscopy and included in the list below:\n\n  * unilateral or bilateral salpingectomy\n  * hysterectomy\n  * ovariectomy\n  * surgery of endometriosis\n  * surgery for cancer of the cervix, endometrium, ovaries\n\nExclusion Criteria:\n\n* Interview revealing disorder entailing unacceptable risk of postoperative complications: coagulation disorder, immune system disorder, evolutive disease, etc.\n* Pregnancy or desire of pregnancy during the study period, breastfeeding\n* Hypersensitivity to Fluorescein or any of its excipients\n* History of life-threatening reaction during angiography\n* Known allergic reactions and hypersensitivity\n* Severe asthma, heart and \u002F or lung disease, diabetes\n* Person on beta-blocker treatment\n* Inability to understand information provided\n* Not covered by a national health insurance scheme, prisoner or under administrative supervision",{"count":60,"type":23},80,[62],"NA","Optical biopsy is a new technology that generates a real-time, cell-based, high-resolution view and analysis of tissues. Observation is instantaneous and non-invasive. This allows reliable and fast diagnosis which facilitates decision making as well as patient management.\n\nThe investigator have already conducted a feasibility study on the use of this new technology to evaluate ovarian and tubal pre-cancerous lesions in laparoscopy. In this new study, he wants to continue investigations, expand its use to other gynecological pathologies, and demonstrate the benefit of such a non-invasive technology in gynecology on the one hand in the diagnosis of lesions but also to appreciate the margins as accurately as possible surgical excision of tumors and \u002F or endometriosis lesions.\n\nThe investigator have set up a prospective monocentric descriptive study. The hypothesis is that optical biopsy by Cellvizio® allows to observe in real time microscopically tissues and to characterize them in the field of gynecological surgery",[30],[66,67,68,69,70,71,72,73],"salpingectomy","Cellvizio®","optical biopsy","unilateral or bilateral salpingectomy","ovariectomy","Endometriosis","surgery for cervical","ovarian cancer","2026-01-14",{"date":76,"type":42},"2026-01-15",{"date":78,"type":42},"2020-06-29",{"date":80,"type":23},"2026-06-29",{"name":82,"class":49},"Hospices Civils de Lyon",{"id":84,"slug":85,"hasResults":11,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":4,"eligibilityCriteria":89,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":90,"targetDuration":4,"studyType":92,"phases":4,"briefSummary":93,"conditions":94,"keywords":97,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":112},"100615029","comparing-cci-and-possum-for-predicting-oncogynecologic-surgery-complications-100615029","NCT07287280","Comparing CCI and POSSUM for Predicting Oncogynecologic Surgery Complications","A Comparison of the Charlson Comorbidity Index (CCI) vs POSSUM Score for Prediction of Perioperative Complications in Patients Undergoing Oncogynecologic Surgery","Inclusion Criteria:\n\n* Age \\> 18 years\n* Patient underwent elective onco-gynecologic surgery\n\nExclusion Criteria:\n\n* Patient required emergency surgery from any indication\n* Patient chart that not contained primary outcome data eg. absent of the anesthetic record",{"count":91,"type":23},300,"OBSERVATIONAL","With the global rates of gynecologic cancers on the rise, optimizing perioperative care is imperative. Accurate risk prediction is essential for enhancing patient care, directing preoperative interventions, and facilitating informed decision-making in oncology. This research compares two widely-used risk assessment tools: the Charlson Comorbidity Index (CCI) and the Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity (POSSUM), in predicting perioperative outcomes. The CCI predominantly addresses comorbidities, providing simplicity and broad applicability, while POSSUM incorporates both physiological and operative factors for a more comprehensive risk assessment. Despite their application across various surgical specialties, the specific utility of these tools in onco-gynecologic surgery remains insufficiently explored. The study aims to evaluate the effectiveness of CCI and POSSUM in predicting perioperative complications, with a focus on the incidence of these complications, length of hospital stay, and 30-day mortality. The implementation of these risk tools may enhance multidisciplinary risk management, thus improving patient outcomes in gynecologic oncology surgery.",[30,95,96],"Risk Assessment","Perioperative Care",[98,99,100,101,102],"Gynecologic oncology surgery","Perioperative complications","Charlson comorbidity index","POSSUM","Mortality","2025-12-16",{"date":105,"type":42},"2025-12-17",{"date":107,"type":42},"2025-09-01",{"date":109,"type":23},"2027-10-31",{"name":111,"class":49},"Mahidol University",1,{"id":114,"slug":115,"hasResults":11,"nctId":116,"briefTitle":117,"officialTitle":118,"acronym":4,"eligibilityCriteria":119,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":120,"targetDuration":4,"studyType":24,"phases":122,"briefSummary":123,"conditions":124,"keywords":125,"overallStatus":128,"whyStopped":4,"lastUpdateSubmitDate":129,"lastUpdatePostDateStruct":130,"startDateStruct":132,"completionDateStruct":134,"leadSponsor":136,"locationsCount":112},"100609969","comparing-intra-abdominal-pressure-during-gynecologic-laparoscopy-100609969","NCT07221487","Comparing Intra-Abdominal Pressure During Gynecologic Laparoscopy","Low Versus Standard Intra-Abdominal Pressure During Gynecologic Laparoscopy: A Randomized Controlled Trial of Postoperative Pain and Recovery Outcomes","Inclusion Criteria:\n\n* Undergoing benign gynecologic laparoscopic surgery with eligible procedures, including the following.\n* Salpingectomy\n* Cystectomy\n* Oophorectomy\n* Myomectomy\n* Hysterectomy.\n* Only those who speak English or Spanish will be recruited, as our validated questionnaires are only available in those languages.\n\nExclusion Criteria:\n\n* Participants with the following diseases will be excluded due to their diseases having pain that may strongly interfere with their perception of pain in the area of surgery.\n* Arthritis\n* Gout\n* Metastatic cancer\n* Pelvic floor disease\n* Headache disorders\n* Herpes zoster or shingles\n* Frozen shoulder\n* Complex regional pain syndrome (CRPS)\n* Slipped disc\n* Sickle cell disease\n* Sciatica\n* Trigeminal neuralgia\n* Fibromyalgia.",{"count":121,"type":23},190,[62],"The goal of this clinical trial is to learn if the level of intra-abdominal pressure during benign gynecologic laparoscopic surgery impacts postoperative pain.\n\nThe main question it aims to answer is:\n\n• Does use of low (8 mmHg) versus standard (15 mmHg) intra-abdominal pressure impact postoperative pain?\n\nResearchers will compare the use of low (8 mmHg) versus standard (15 mmHg) intra-abdominal pressure.\n\nParticipants will:\n\n* Undergo their regular scheduled gynecologic laparoscopic surgery\n* Complete pain measures one hour, 3 hours, and 24 hours after surgery",[30],[126,127],"pain","abdominal pressure","NOT_YET_RECRUITING","2025-10-27",{"date":131,"type":42},"2025-10-29",{"date":133,"type":23},"2025-11",{"date":135,"type":23},"2026-05",{"name":137,"class":49},"Nassau University Medical Center"]